The Bayer Pharma Data Science & Artificial Intelligence (DS&AI) F2F meeting in Madrid was a great event! The motto Connect, Clarify & Commit came to life as we connected during networking sessions, breakout sessions and social events. At the poster session we learned about our progress embedding a product mindset and driving operational excellence, closely collaborating with our partners across R&D. We heard presentations, took part in discussions, unconference sessions, asked questions and shared ideas, setting foundations for the growth of DS&AI beyond 2023. The use of POAPs was a definite social success and I am sure you did not miss Jesús’ enthusiasm as he gave an overview of this new tool. By promoting its use, we drive new ways of using this sustainable and effective tool, ultimately helping to innovate its use by doctors, within clinical trials, for patients and more. There were fun elements as well, like the final night, where our very own flash-mob took to the dance floor and we danced until way past midnight! All this was made possible by the org team: Anke Ebert, Larsen Schnadhorst, Kathleen Thies, Sheila Elz, Stefanie Holt-Noreiks and Claudia Vogt. They have done an excellent job coordinating the event, with the perfect balance of presentations, speakers, entertainment, and networking. Now let us make sure we continue to further the impact we have on bringing innovative medicines to our patients. Sai Jasti, Head of DS&AI https://bayer.com/poap

Part of the Clinical Trial Technology and strategy group. Bringing new technology and services to our organisation

I am Lead Business Technology Manager with Bayer, from Hyderabad, India. I have total 14 years of experience in various capacities on both business and technology side.

it was great meeting you during the DS&AI event in Madrid. I'd be happy if you get in touch with me, ☕️ if you want to drink a coffee or 💊 if you want chat about digital transformation in chemical & pharmaceutical drug development 🐶🌎🧪📸 🧘‍♀️🏔️🧑‍🍳🚐 🍱

Data Acquisition Technology Expert (Associate Director) at Bayer Healthcare Pharmaceuticals

DS3 Supporting ALYCE/RDC and DaVE